National trends in osteoporosis medication use among Medicare beneficiaries with and without Alzheimer's disease/related dementias.

Peyton ArmstrongYong-Fang KuoPeter CramJordan WestraMukaila A Raji

Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)

ADRD patients received OP drugs at a lower rate than their non-ADRD counterparts. More research is needed on when to prescribe or deprescribe OP drugs in the context of different ADRD severity, patient preferences, remaining life expectancy, and time-to-benefit from OP drugs.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
postmenopausal women
peritoneal dialysis
drug induced
quality improvement
case report
healthcare
bone mineral density